Brexanolone (Lipocine)

布瑞诺龙 (Lipocine)

Report date: 2025/08/29 17:39:28

Base Information

Drug NameBrexanolone (Lipocine)
Drug Alias NameLPCN1154LPCN 1154LPCN 1154A
ClassificationSmall molecules > Steroids
Mechanisms of ActionGamma-aminobutyric acid A receptor modulators
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsPeripartum DepressionDepression, Postpartum
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesLipocine Inc
China Registration ClassN/A

Develop Information

Active CompaniesLipocine Inc
Inactive CompaniesN/A
Active IndicationsPeripartum DepressionDepression, Postpartum
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A